APA (7th ed.) Citation

Ibrahim, T. S., Moustafa, A. H., Almalki, A. J., Allam, R. M., Althagafi, A., Md, S., & Mohamed, M. F. A. (2021). Novel chalcone/aryl carboximidamide hybrids as potent anti-inflammatory via inhibition of prostaglandin E2 and inducible NO synthase activities: Design, synthesis, molecular docking studies and ADMET prediction. Journal of Enzyme Inhibition & Medicinal Chemistry, 36(1), 1067. https://doi.org/10.1080/14756366.2021.1929201

Chicago Style (17th ed.) Citation

Ibrahim, Tarek S., Amr H. Moustafa, Ahmad J. Almalki, Rasha M. Allam, Abdulhamid Althagafi, Shadab Md, and Mamdouh F. A. Mohamed. "Novel Chalcone/aryl Carboximidamide Hybrids as Potent Anti-inflammatory via Inhibition of Prostaglandin E2 and Inducible NO Synthase Activities: Design, Synthesis, Molecular Docking Studies and ADMET Prediction." Journal of Enzyme Inhibition & Medicinal Chemistry 36, no. 1 (2021): 1067. https://doi.org/10.1080/14756366.2021.1929201.

MLA (9th ed.) Citation

Ibrahim, Tarek S., et al. "Novel Chalcone/aryl Carboximidamide Hybrids as Potent Anti-inflammatory via Inhibition of Prostaglandin E2 and Inducible NO Synthase Activities: Design, Synthesis, Molecular Docking Studies and ADMET Prediction." Journal of Enzyme Inhibition & Medicinal Chemistry, vol. 36, no. 1, 2021, p. 1067, https://doi.org/10.1080/14756366.2021.1929201.